Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations

Journal of Molecular Biology

Volumn 328, Issue 5, 2003, Pages 1083-1089

  Oomen, Clasien J ^a,b   Hoogerhout, Peter ^b   Bonvin, Alexandre M J J ^a   Kuipers, Betsy ^b   Brugghe, Humphrey ^b   Timmermans, Hans ^b   Haseley, Simon R ^a   Van Alphen, Loek ^b   Gros, Piet ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Beta turn; Immunogenicity; Molecular dynamics; Peptide vaccine; Structure based design

Indexed keywords

CYCLOPEPTIDE; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; CRYSTALLOGRAPHY; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; IMMUNOGENICITY; MEMBRANE VESICLE; MOLECULAR DYNAMICS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 0242418197     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00377-2     Document Type: Article

References (34)

1. Arnon R., Van Regenmortel M.H. Structural basis of antigenic specificity and design of new vaccines. FASEB J. 6:1992;3265-3274.
2. Langeveld J.P.M., Casal J.I., Osterhaus A.D.M.E., Cortes E., de Swart R., Vela C., et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 68:1994;4506-4513.
3. Muller S., Plaue S., Samama J.P., Valette M., Briand J.P., Van Regenmortel M.H.V. Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin. Vaccine. 8:1990;308-314.
4. Luo Y., Zeng Q., Glisson J.R., Jackwood M.W., Cheng I.H., Wang C. Sequence analysis of Pasteurella multocida major outer membrane protein (OmpH) and application of synthetic peptides in vaccination of chickens against homologous strain challenge. Vaccine. 17:1999;821-831.
5. Christodoulides M., McGuinness B.T., Heckels J.E. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide. J. Gen. Microbiol. 139:1993;1729-1738.
6. Hoogerhout P., Donders E.M., van Gaans-van den Brink J.A., Kuipers B., Brugghe H.F., van Unen L.M., et al. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis. Infect. Immun. 63:1995;3473-3478.
7. Sundaram R., Dakappagari N.K., Kaumaya P.T. Synthetic peptides as cancer vaccines. Biopolymers. 66:2002;200-216.
8. Meloen R.H., Puijk W.C., Slootstra J.W. Mimotopes: realization of an unlikely concept. J. Mol. Recogn. 13:2000;352-359.
9. Craig L., Sanschagrin P.C., Rozek A., Lackie S., Kuhn L.A., Scott J.K. The role of structure in antibody cross-reactivity between peptides and folded proteins. J. Mol. Biol. 281:1998;183-201.
10. Ghiara J.B., Ferguson D.C., Satterthwait A.C., Dyson H.J., Wilson I.A. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. J. Mol. Biol. 266:1997;31-39.
11. Cuniasse P., Thomas A., Smith J.C., Thanh H.L., Leonetti M., Menez A. Structural basis of antibody cross-reactivity: solution conformation of an immunogenic peptide fragment containing both T and B epitopes. Biochemistry. 34:1995;12782-12789.
12. Valero M.L., Camarero J.A., Haack T., Mateu M.G., Domingo E., Giralt E., Andreu D. Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility. J. Mol. Recogn. 13:2000;5-13.
13. Fischer M.J., Kuipers C., Hofkes R.P., Hofmeyer L.J., Moret E.E., de Mol N.J. Exploring computational lead optimisation with affinity constants obtained by surface plasmon resonance for the interaction of PorA epitope peptides with antibody against Neisseria meningitidis. Biochim. Biophys. Acta. 1568:2001;205-215.
14. Van Regenmortel M.H. Antigenicity and immunogenicity of synthetic peptides. Biologicals. 29:2001;209-213.
15. Koebnik R., Locher K.P., Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol. Microbiol. 37:2000;239-253.
16. van der Ley P., Heckels J.E., Virji M., Hoogerhout P., Poolman J.T. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:1991;2963-2971.
17. van den Elsen J.M., Herron J.N., Hoogerhout P., Poolman J.T., Boel E., Logtenberg T., et al. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide. Proteins: Struct. Funct. Genet. 29:1997;113-125.
18. Sibanda B.L., Blundell T.L., Thornton J.M. Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J. Mol. Biol. 206:1989;759-777.
19. Hutchinson E.G., Thornton J.M. A revised set of potentials for beta-turn formation in proteins. Protein Sci. 3:1994;2207-2216.
20. Hutchinson E.G., Sessions R.B., Thornton J.M., Woolfson D.N. Determinants of strand register in antiparallel beta-sheets of proteins. Protein Sci. 7:1998;2287-2300.
21. Smith C.K., Regan L. Guidelines for protein design: the energetics of beta sheet side chain interactions. Science. 270:1995;980-982.
22. Wouters M.A., Curmi P.M. An analysis of side chain interactions and pair correlations within antiparallel beta-sheets: the differences between backbone hydrogen- bonded and non-hydrogen-bonded residue pairs. Proteins: Struct. Funct. Genet. 22:1995;119-131.
23. Gibbs A.C., Bjorndahl T.C., Hodges R.S., Wishart D.S. Probing the structural determinants of type II′ beta-turn formation in peptides and proteins. J. Am. Chem. Soc. 124:2002;1203-1213.
24. Ramirez-Alvarado M., Kortemme T., Blanco F.J., Serrano L. Beta-hairpin and beta-sheet formation in designed linear peptides. Bioorg. Med. Chem. 7:1999;93-103.
25. Ramirez-Alvarado M., Blanco F.J., Niemann H., Serrano L. Role of beta-turn residues in beta-hairpin formation and stability in designed peptides. J. Mol. Biol. 273:1997;898-912.
26. Griffiths-Jones S.R., Maynard A.J., Searle M.S. Dissecting the stability of a beta-hairpin peptide that folds in water: NMR and molecular dynamics analysis of the beta-turn and beta-strand contributions to folding. J. Mol. Biol. 292:1999;1051-1069.
27. Blanco F., Ramirez-Alvarado M., Serrano L. Formation and stability of beta-hairpin structures in polypeptides. Curr. Opin. Struct. Biol. 8:1998;107-111.
28. Weisshoff H., Prasang C., Henklein P., Frommel C., Zschunke A., Mugge C. Mimicry of beta II′-turns of proteins in cyclic pentapeptides with one and without D-amino acids. Eur. J. Biochem. 259:1999;776-788.
29. van der Ley P., van der Biezen J., Poolman J.T. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine. 13:1995;401-407.
30. Vermont C., Van den Dobbelsteen G. Neisseria meningitidis serogroup B: laboratory correlates of protection. FEMS Immun. Med. Microbiol. 34:2002;89-96.
31. Scott W.R.P., Huenenberger P.H., Ilario G.T., Mark A.E., Billeter S.R., Fennen J., et al. The GROMOS biomolecular simulation program package. J. Phys. Chem. ser. A. 103:1999;3596-3607.
32. Bonvin A.M., van Gunsteren W.F. Beta-hairpin stability and folding: molecular dynamics studies of the first beta-hairpin of tendamistat. J. Mol. Biol. 296:2000;255-268.
33. Sacchi C.T., Lemos A.P., Brandt M.E., Whitney A.M., Melles C.E., Solari C.A., et al. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5:1998;845-855.
34. Anonymous, (1994). BIAapplications Handbook. Pharmacia Biosensor AB, Uppsala, Sweden.